Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Agitation in Patients With Dementia of the Alzheimer's Type”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Testing effectiveness (Phase 2)Study completedNCT02471196
What this trial is testing

Efficacy of ORM-12741 on Agitation/Aggression Symptoms in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Orion Corporation, Orion Pharma 308
Large-scale testing (Phase 3)Ended earlyNCT06736509
What this trial is testing

An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension Study

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's TypeAlzheimer DiseaseAgitation, Psychomotor
Axsome Therapeutics, Inc. 139
Large-scale testing (Phase 3)Study completedNCT02442765
What this trial is testing

Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Development & Commercialization, Inc. 387
Post-approval studies (Phase 4)Study completedNCT00401167
What this trial is testing

Memantine for Agitation and Aggression in Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Sunnybrook Health Sciences Centre 31
Testing effectiveness (Phase 2)Study completedNCT01584440
What this trial is testing

Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's Disease

Who this might be right for
AgitationAlzheimer's Disease
Avanir Pharmaceuticals 220
Testing effectiveness (Phase 2)UnknownNCT05239390
What this trial is testing

SCI-110 for Alzheimer Disease and Agitation

Who this might be right for
Alzheimer Disease
The Israeli Medical Center for Alzheimer's 20
Large-scale testing (Phase 3)Ended earlyNCT02817906
What this trial is testing

ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease

Who this might be right for
Agitation in Dementia, Including Alzheimer's Disease
Intra-Cellular Therapies, Inc. 177
Large-scale testing (Phase 3)Study completedNCT03393520
What this trial is testing

Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Development & Commercialization, Inc. 601
Large-scale testing (Phase 3)Study completedNCT00097916
What this trial is testing

An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients With Moderate to Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Forest Laboratories 34
Testing effectiveness (Phase 2)Ended earlyNCT03044249
What this trial is testing

MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression

Who this might be right for
PsychosisDementiaAggression+2 more
Mediti Pharma Inc. 81
Large-scale testing (Phase 3)Study completedNCT05557409
What this trial is testing

Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's TypeAlzheimer DiseaseAgitation
Axsome Therapeutics, Inc. 408
Not applicableStudy completedNCT00015548
What this trial is testing

CATIE-Alzheimer's Disease Trial

Who this might be right for
Alzheimer's Disease
National Institute of Mental Health (NIMH) 450
Not applicableStudy completedNCT02686190
What this trial is testing

Effects of Light-therapy in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Assistance Publique - Hôpitaux de Paris 91
Large-scale testing (Phase 3)Ended earlyNCT02168920
What this trial is testing

Aripiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type

Who this might be right for
Agitation Associated With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Co., Ltd. 150
Not applicableUnknownNCT02147652
What this trial is testing

Personalized Music Therapy and Agitation in Dementia

Who this might be right for
Alzheimer's DiseaseVascular Dementia
University Health Network, Toronto 60
Testing effectiveness (Phase 2)Looking for participantsNCT04436081
What this trial is testing

Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementiaMajor Neurocognitive Disorder With Aggressive Behavior
Eastern Virginia Medical School 40
Large-scale testing (Phase 3)Study completedNCT04947553
What this trial is testing

Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease Agitation

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's TypeAlzheimer DiseaseAgitation, Psychomotor
Axsome Therapeutics, Inc. 456
Large-scale testing (Phase 3)Ended earlyNCT02446132
What this trial is testing

Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Development & Commercialization, Inc. 1,197
Large-scale testing (Phase 3)Study completedNCT04797715
What this trial is testing

Assessing Clinical Outcomes in Alzheimer's Disease Agitation

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's TypeAlzheimer DiseaseAgitation,Psychomotor
Axsome Therapeutics, Inc. 178
Testing effectiveness (Phase 2)Study completedNCT00012857
What this trial is testing

Pain Management and Behavioral Outcomes in Patients With Dementia

Who this might be right for
DementiaAlzheimer Disease, PainBehavior, Agitation
US Department of Veterans Affairs 66
Load More Results